Your browser doesn't support javascript.
Analyzing complications and implementing solutions in a pediatric inguinal hernia cooperation program in Equatorial Guinea: a prospective cohort study.
Rodríguez de Alarcón García, Jaime; Úbeda Pascual, Amalia; Fanjul Gómez, María; Morató Robert, Pablo; Espinosa Góngora, Rocío; Martínez García, Ernesto; Román Guerrero, Carlos; Abaga Abaga, Santiago Jaime; Soto Beauregard, Carmen.
  • Rodríguez de Alarcón García J; Department of Pediatric Surgery, Hospital Clínico San Carlos, Madrid, Spain.
  • Úbeda Pascual A; Medical Faculty, Universidad Francisco de Vitoria, Madrid, Spain.
  • Fanjul Gómez M; Medical Faculty, Universidad Francisco de Vitoria, Madrid, Spain.
  • Morató Robert P; Department of Pediatric Surgery, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • Espinosa Góngora R; Department of Pediatric Surgery, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
  • Martínez García E; Department of Pediatric Surgery, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
  • Román Guerrero C; Department of Anesthesiology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
  • Abaga Abaga SJ; Department of Anesthesiology, Hospital Universitario de la Princesa, Madrid, Spain.
  • Soto Beauregard C; Medical Center, SOS Children's Villages, Bata, Equatorial Guinea.
Ann Pediatr Surg ; 19(1): 5, 2023.
Article in English | MEDLINE | ID: covidwho-2196577
ABSTRACT

Background:

Few studies have evaluated the efficacy of short-term medical missions. This study was aimed to evaluate complication rates and determine the effects of protocol changes in a pediatric inguinal hernia campaign in Equatorial Guinea and analyze post-operative follow-up capacity.

Methods:

In this prospective observational cohort study, we evaluated two patient cohorts (group A, 2017-2018; group B, 2019) treated during campaigns in Equatorial Guinea for congenital inguinal pathology (hernia, hydrocele, and cryptorchidism). Patients aged < 18 years treated in referral campaigns were included. Complications occurring up to 6 months post-operatively were evaluated. Two stages were defined Stage 1, wherein, complication rate in group A was compared to that in a control group from a tertiary hospital in Spain (with a case-control ratio of 12, paired according to age, sex and diagnosis); stage 2, wherein, complication rates between groups A and B were compared. Group B received a single dose of prophylactic amoxicillin-clavulanic acid. Follow-up capacity was assessed through follow-up appointments.

Results:

In stage 1, complication and surgical site infection (SSI) rates were 21.3% and 7.4% in group A (n = 94), and 5.8% (p < 0.001) and 0.5% (p = 0.012) in the control group, respectively. Group A had 20.2% loss-to-follow-up. In group B (n = 62), 6-month postoperative follow-up could not be assessed owing to restrictions due to the COVID-19 pandemic, so only early complications were considered in stage 2, were complication and surgical site infection rates were 18.1% and 7.4% in group A and 11.3% (p = 0.350) and 1.6% (p = 0.150) in group B.

Conclusion:

Our results showed higher than expected complication rates. Pre-operative prophylactic antibiotic could not show to reduce SSI. Further studies are needed to reduce complication rates in these campaigns. Patient loss-to-follow-up ratio warrants considering new strategies.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Ann Pediatr Surg Year: 2023 Document Type: Article Affiliation country: S43159-022-00237-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Ann Pediatr Surg Year: 2023 Document Type: Article Affiliation country: S43159-022-00237-5